Nalaganje...
Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell’Adulto Multiple Myeloma Working Party study
INTRODUCTION: A still not well defined proportion of patients with multiple myeloma (MM) and eligible for autologous stem cell transplantation (AuSCT) fails to mobilize CD34+ peripheral blood stem cells (PBSC) at all or to collect an adequate number for a safe procedure or sufficient for multiple tr...
Shranjeno v:
izdano v: | Stem Cell Res Ther |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
BioMed Central
2015
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4425876/ https://ncbi.nlm.nih.gov/pubmed/25889496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-015-0033-1 |
Oznake: |
Označite
Brez oznak, prvi označite!
|